Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology Clinics, 2025. Verfasst von Charles Yao-Cheng Ho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand. Electronic address: charles.ho4168@gmail.com. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Death, Sudden, Cardiac, Arrhythmias, Cardiac, Electric Countershock. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death (SCD) and improve survival in patients with a history of life-threatening arrhythmia or sudden cardiac arrest, and in select populations at high risk of SCD due to ventricular arrhythmias. However, patients with ICDs may receive inappropriate or unnecessary shocks, which have been associated with pro-arrhythmia, psychological sequelae, poor quality of life, and increased mortality. The benefits and risks of ICD therapy are therefore directly impacted on by physician operative and programming decisions. This article aims to provide a detailed review of transvenous ICD programming as guided by clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand. Electronic address: charles.ho4168@gmail.com.
- Department of Cardiology, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand; Waikato Clinical School, University of Auckland, Waikato Hospital, 183 Pembroke Street, Hamilton 3204, New Zealand.
Zitieren
APA
Yao-Cheng Ho, C., & Stiles, M. K. (2025). Lead Management. Cardiology Clinics. https://doi.org/10.1016/j.ccl.2025.05.004
Vancouver
Yao-Cheng Ho C, Stiles MK. Lead Management. Cardiology Clinics. 2025. doi:10.1016/j.ccl.2025.05.004
BibTeX
@article{YaoChengHo2025,
author = {Yao-Cheng Ho, Charles and Stiles, Martin K},
title = {Lead Management},
journal = {Cardiology Clinics},
year = {2025},
doi = {10.1016/j.ccl.2025.05.004}
}
EUVIMED